Overall Recruitment Status: Terminated

Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours

Study to Evaluate the Safety and Efficacy of IPN59011 in Improving the Appearance of Moderate to Severe Upper Facial Lines.

Dysport in Vulvodynia Phase II Study

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis – Study 2

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis – Study 1

Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly

Study to evaluate the safety and activity (including distribution) of 177Lu-3BP-227 in subjects with solid tumours expressing neurotensin receptor type 1.

A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072

Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2)

Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs